2198
G. Tanabe et al. / Bioorg. Med. Chem. Lett. 19 (2009) 2195–2198
7. Minami, Y.; Kuriyama, C.; Ikeda, K.; Kato, A.; Takebayashi, K.; Adachi, I.; Fleet,
W. J. G.; Kettawan, A.; Okamoto, T.; Asano, N. Bioorg. Med. Chem. 2008, 16, 2734.
8. (a) Cimetiere, B.; Jacob, L.; Julia, M. Tetrahedron Lett. 1986, 27, 6329; (b)
Cimetiere, B.; Jacob, L.; Julia, M. Bull. Soc. Chim. Fr. 1991, 128, 926; (c) Okuma,
K.; Nakamura, S.; Ohta, H. Heterocycles 1987, 26, 2343.
salacinol (3c) concluded that the compound isolated by Asano
group was formate of de-O-sulfated salacinol (3c). The authors re-
cently detected de-O-sulfated salacinol (3) and de-O-sulfated
kotalanol (4) in the cold water extract by means of LC–MS analysis.
Further studies on the evaluation of extracts involving the contri-
bution of these de-O-sulfates (3 and 4) are in progress.
9. Abushanab, E.; Vemishetti, P.; Leiby, R. W.; Singh, H. K.; Mikkilineni, A. B.; Wu,
D. C.-J.; Saibaba, R.; Panzica, R. P. J. Org. Chem. 1988, 53, 2598.
10. Ghavami, A.; Johnston, B. D.; Pinto, B. M. J. Org. Chem. 2001, 66, 2312.
11. Compound
a
-11d: Colorless oil. ½a D23
ꢂ
+4.25 (c 2.43, CHCl3). IR (neat) 3503, 1496,
1452, 1400, 1362, 1211, 1087 cmꢁ1
.
1H NMR (500 MHz, CDCl3) d 3.62 (1H, dd,
Acknowledgements
J = 10.6, 3.5 Hz, H-40a), 3.67 (2H, d-like, J = 3.2 Hz, H-1a, H-1b), 3.68–3.73 (3H,
m, H-40b, H-5a and H-5b), 3.74–3.77 (1H, m, H-30), 3.78 (1H, dd, J = 13.2, 6.9 Hz,
H-1a0), 3.85 (1H, dd, J = 13.2, 3.8 Hz, H-1b0), 4.05 (1H, br-t like, J = ca. 7.6 Hz, H-
4), 4.14 (1H, br s, OH), 4.19 (1H, br t-like, J = ca. 1.5 Hz, H-3), 4.29/4.36 (each
1H, d, J = 11.8 Hz, PhCH2), 4.31–4.36 (2H, m, H-2, H-20), 4.43–4.53 (6H, m,
PhCH2), 4.58/4.64 (each 1H, d, J = 11.2 Hz, PhCH2), 7.08–7.35 (25H, m, arom.).
13C NMR (125 MHz, CDCl3) d 48.1 (C-1), 50.8 (C-10), 66.0 (C-4), 66.7 (C-5), 68.5
(C-20), 68.7 (C-40), 71.7/72.0/72.9/73.4/73.5 (PhCH2), 79.5 (C-30), 82.3 (C-3) 82.5
(C-2), 127.8/127.88/127.90/128.0/128.1/128.2/128.3/128.36/128.40/128.43/
128.47/128.51/128.6/128.7 (d, arom.), 135.9/136.1/136.8/137.5/137.6 (s,
arom.). FAB-MS m/z 705 [MꢁBF4]+ (pos.), 87 [BF4]ꢁ (neg.). HR-FAB-MS m/z
705.3220 (C44H49O6S requires 705.3250), 87.0027 (BF4 requires 87.0030).
12. A mixture of salacinol (1, 50 mg, 0.15 mmol) and 5% methanolic hydrogen
chloride (5 ml) was heated under reflux for 1 h. After removal of the solvent,
the residue (60 mg) was purified on column chromatography (AcOEt/MeOH/
This work was supported by ‘High-Tech Research Center’ Pro-
ject for Private Uni: matching fund subsidy from MEXT (Ministry
of Education, Culture, Sports. Science and Technology), 2007–2011.
References and notes
1. (a) Yoshikawa, M.; Murakami, T.; Shimada, H.; Matsuda, H.; Yamahara, J.;
Tanabe, G.; Muraoka, O. Tetrahedron Lett. 1997, 38, 8367; (b) Yoshikawa, M.;
Murakami, T.; Yashiro, K.; Matsuda, H. Chem. Pharm. Bull. 1998, 46, 1339; (c)
Yoshikawa, M.; Morikawa, T.; Matsuda, H.; Tanabe, G.; Muraoka, O. Bioorg. Med.
Chem. 2002, 10, 1547.
2. (a) Tanabe, G.; Yoshikai, K.; Hatanaka, T.; Yamamoto, M.; Shao, Y.; Minematsu,
T.; Muraoka, O.; Wang, T.; Matsuda, H.; Yoshikawa, M. Bioorg. Med. Chem. 2007,
15, 3926; (b) Yoshikawa, M.; Xu, F.; Nakamura, S.; Wang, T.; Matsuda, H.;
Tanabe, G.; Muraoka, O. Heterocycles 2008, 75, 1397.
3. (a) Muraoka, O.; Ying, S.; Yoshikai, K.; Matsuura, Y.; Yamada, E.; Minematsu, T.;
Tanabe, G.; Matsuda, H.; Yoshikawa, M. Chem. Pharm. Bull. 2001, 49, 1503; (b)
Muraoka, O.; Yoshikai, K.; Takahashi, H.; Minematsu, T.; Lu, G.; Tanabe, G.;
Wang, T.; Matsuda, H.; Yoshikawa, M. Bioorg. Med. Chem. 2006, 14, 500; (c)
Mohan, S.; Pinto, B. M. Carbohydr. Res. 2007, 342, 1551; (d) Choubdar, N.; Sim,
L.; Rose, D. R.; Pinto, B. M. Carbohydr. Res. 2008, 343, 951; (e) Nasi, R.; Patrick, B.
O.; Sim, L.; Rose, D. R.; Pinto, B. M. J. Org. Chem. 2008, 73, 6172. and references
cited therein.
ꢁ
H2O, 20:4:1) to give the methyl sulfate 3a (48 mg, 88%). Dowex 1-X2 (HCO2
form, 1 g) was well washed with H2O. An aqueous solution of 3a (10 ml) was
treated with the half volume (ca. 500 mg) of the resin to give 3c (32 mg, 82%)
as an oil. Another half of the resin was washed with H2O (10 ml), and the
washings was concentrated in vacuo. The residue showed no signals due to
HCO2 moiety in its 1H NMR spectrum in D2O. Compound 3c: IR (neat) 3360,
ꢁ
1597, 1388, 1350, 1249, 1219, 1069, 1022 cmꢁ1 1H NMR (700 MHz, D2O,
.
internal standard: TSP) d 3.66 (dd-like, J = 11.4, 5.6 Hz, H-40a), 3.75 (ddd, J = 6.8,
5.6, 3.6 Hz, H-30), 3.78 (dd, J = 11.4, 3.6 Hz, H-40b), 3.79 (dd, J = 13.2, 9.4 Hz, H-
10a), 3.90 (dd, J = 13.2, 3.8 Hz, H-1a), 3.91 (dd, J = 13.2, 3.0 Hz, H-10b), 3.95 (dd,
J = 13.2, 3.2 Hz, H-1b), 3.96 (dd, J = 12.0, 9.2 Hz, H-5a), 4.11 (ddd, J = 9.2, 4.8,
2.6 Hz, H-4), 4.15 (dd, J = 12.0, 4.8 Hz, H-5b), 4.17 (ddd, J = 9.4, 6.8, 3.0 Hz, H-
20), 4.47 (dd-like, J = 3.2, 2.6 Hz, H-3), 4.77 (ddd-like, J = 3.8, 3.2, 3.2 Hz, H-2),
8.46 (1H, s, HCO2). 13C NMR (175 MHz, D2O, internal standard: TSP) d 51.0 (C-
1), 52.3 (C-10), 61.9 (C-5), 64.7 (C-40), 70.3 (C-20), 72.7 (C-4), 76.2 (C-30), 79.7 (C-
2), 80.3 (C-3), 173.7 (HCO2ꢁ). The spectral properties of 3c in pyridine-d5/D2O
(5:1) are presented in Table 1.
4. Tanabe, G.; Sakano, M.; Minematsu, T.; Matusda, H.; Yoshikawa, M.; Muraoka,
O. Tetrahedron 2008, 64, 10080–10086.
5. (a) Ozaki, S.; Oe, H.; Kitamura, S. J. Nat. Prod. 2008, 71, 981; (b) Oe, H.; Ozaki, S.
Biosci. Biotechnol. Biochem. 2008, 72, 1962.
6. Muraoka, O.; Xie, W.; Tanabe, G.; Amer, F. A. M.; Minematsu, T.; Yoshikawa, M.
Tetrahedron Lett. 2008, 49, 7315.